Drug treats PCa patients with bone metastases

Novartis offers zoledronic acid injection (ZOMETA) for the treatmentof patients with documented bone metastases from solid tumors, includingprostate cancer, in conjunction with standard antineoplastic therapy.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.